1.1300
-0.0100
(-0.88%)
At close: 4:00:02 PM EST
1.1100
-0.02
(-1.77%)
After hours: 4:16:17 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AULT MILTON C III Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Aug 6, 2024 | -- |
| HORNE WILLIAM B Director | Conversion of Exercise of derivative security | Feb 24, 2023 | 1,000,000 |
| JACKMAN STEPHAN Chief Executive Officer | Purchase | Apr 28, 2023 | 45,500 |
| KATZOFF DAVID J Chief Financial Officer | Purchase | Sep 26, 2023 | 81,000 |
| MCGRATH LYNNE FAHEY Director | Sale | Dec 26, 2023 | -- |
Related Tickers
DRMA Dermata Therapeutics, Inc.
1.2000
-4.76%
LYRA Lyra Therapeutics, Inc.
0.1955
-2.59%
GRTX Galera Therapeutics, Inc.
0.0510
+7.14%
VRPX Virpax Pharmaceuticals, Inc.
0.3650
-0.16%
ARTL Artelo Biosciences, Inc.
1.1600
+4.50%
KTTA Pasithea Therapeutics Corp.
2.5600
-10.49%
ZVSA ZyVersa Therapeutics, Inc.
1.4700
+24.58%
WINT Windtree Therapeutics, Inc.
0.2552
-5.09%
IMMX Immix Biopharma, Inc.
2.1000
-6.67%
BCTX BriaCell Therapeutics Corp.
0.4028
-6.74%